Kidney function may change how diabetes drug works
NCT ID NCT07385547
First seen Feb 04, 2026 · Last updated Jun 16, 2026 · Updated 19 times
Summary
This study tests a single dose of a new long-acting diabetes medicine (GL0034) in 40 adults with different levels of kidney function. Researchers want to see if kidney problems change how the drug moves through the body. The goal is to find the right dose for people with kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE II DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Clinical Research Center (OCRC)
NOT_YET_RECRUITINGOrlando, Florida, 32809, United States
-
Panax Clinical Research
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Syneos Miami
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.